All Publications for Dr. Richard Rozek


Switching Pharmaceutical Products from Prescription to Over-the-Counter: The Debate in the USPublished Article
2012-12-01
By Dr. Richard Rozek
Economics as a Guide to Developing Public Policies for Biosimilar Pharmaceutical ProductsPublished Article
2012-11-01
By Dr. Richard Rozek
An Economic Perspective on Small and Large Molecule Pharmaceutical Technologies (Una perspectiva economica sobre las tecnologias farmaceuticas de moleculas pequeñas y grandes)Published Article
2011-08-01
By Dr. Richard Rozek
Risk and Regulatory Factors Affecting Location Decisions by Research-Based Pharmaceutical CompaniesPublished Article
2011-01-31
By Dr. Richard Rozek
Key Factors in Attracting Internationally Mobile Investments by the Research-Based Pharmaceutical IndustryReport
2007-09-21
By Dr. Richard Rozek et al.
Patent Wars and Authorised Generics in the USA: Assessing the IssuesPublished Article
2007-05-01
By Dr. Richard Rozek et al.
The Intellectual Property Debate: Perspectives from Law, Economics and Political EconomyBook
2006-08-01
Contributions by Dr. Richard Rozek
A Market-Based Approach for Tangible Property Transfer PricingPublished Article
2005-03-16
By Dr. Richard Rozek et al.
Economic Issues Raised in the FDA’s Proposed Rule on Removing the Essential-Use Designation for Albuterol MDIsReport
2004-08-13
By Dr. Richard Rozek et al.
Using In-country Comparables to Measure the Returns Due Pharmaceutical Marketing and Distribution AffiliatesPublished Article
2003-12-01
By Dr. Richard Rozek et al.